1.5 Proteinanalytik
Filtern
Erscheinungsjahr
- 2021 (11) (entfernen)
Dokumenttyp
- Sonstiges (5)
- Zeitschriftenartikel (2)
- Vortrag (2)
- Posterpräsentation (2)
Referierte Publikation
- nein (11) (entfernen)
Schlagworte
- Antibodies (2)
- Antikörper (2)
- HPLC (2)
- SDS-PAGE (2)
- 18HTL10 (1)
- ACE2-Rezeptor (1)
- ADC (1)
- Acid (1)
- Affinity (1)
- Affinity Chromatography (1)
- Affinity column (1)
- Amino acid analysis (1)
- Antibody drug conjugate (1)
- Antibody quantification (1)
- Antibody screening (1)
- Antibody-gated materials (1)
- Biochemische Sensoren (1)
- Biosensor (1)
- Border surveillance (1)
- CMOS camera (1)
- COVID-19 (1)
- CardioMet (1)
- Click chemistry (1)
- Clones (1)
- Cmos (1)
- Confiscation (1)
- Copper-catalyzed (1)
- Corona (1)
- Customs (1)
- DM1 (1)
- Database (1)
- Detection (1)
- Digestion (1)
- Diode laser (1)
- Drug search (1)
- Drug trafficking (1)
- Dy-654 (1)
- E. coli (1)
- ECL (1)
- ELISA (1)
- EMPIR (1)
- Epifluorescence (1)
- Evanescent wave (1)
- Expression (1)
- FPLC (1)
- Fingerprint (1)
- Flowcell (1)
- Fragment (1)
- Glass (1)
- HMX (1)
- Halomonas elongata (1)
- Herceptin (1)
- Horizon 2020 (1)
- Human antibody (1)
- Hydrolysis (1)
- Illicit drug (1)
- Immunosensor (1)
- International drug trade (1)
- Lab on a Chip (1)
- Lab on a chip (1)
- Lab-on-a-chip (1)
- Lateral flow assay (1)
- Linker (1)
- Luminol (1)
- MALDI-TOF-MS (1)
- MMAE (1)
- MST (1)
- Mass spectrometry (1)
- Mertansine (1)
- Microfluidic mixing (1)
- Monoclonal antibodies (1)
- Monolith (1)
- Monolithic material (1)
- Monomethyl Auristatin E (1)
- Nanobody (1)
- Narcotics (1)
- PETN (1)
- Payload (1)
- Peptide (1)
- Peptide analysis (1)
- Peptides (1)
- Periplasma (1)
- Peroxidase (1)
- Purification (1)
- Pyrethroids detection (1)
- RBD (1)
- RDX (1)
- Round robin test (1)
- SARS-CoV-2 (1)
- SPR (1)
- Schnelltests (1)
- Sensor (1)
- Separation (1)
- Silanization (1)
- Sintered glass (1)
- Site-selective bioconjugation (1)
- Solid support (1)
- Spike-Protein (1)
- Surface derivatization (1)
- Toxin (1)
- Trastuzumab (1)
- Trypsin (1)
- Vhh (1)
- Virus (1)
- Vor-Ort-Analytik (1)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (2)
Under the auspices of the Protein Analysis Working Group (PAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a pilot study, CCQM-P216, was coordinated by the Chinese National Institute of Metrology (NIM), National Research Council of Canada (NRC) and the Bureau International des Poids et Mesures (BIPM). Eleven Metrology Institutes or Designated Institutes and the BIPM participated in the first phase of the pilot study (Part 1). The purpose of this pilot study was to develop measurement capabilities for larger proteins using a recombinant humanized IgG monoclonal antibody against Spike glycoprotein of SARS-CoV-2 (Anti-S IgG mAb) in solution. The first phase of the study was designed to employ established methods that had been previously studies by the CCQM Protein Analysis Working Group, involving the digestion of protein down to the peptide or amino acid level. The global coronavirus pandemic has also led to increased focus on antibody quantitation methods. IgG are among the immunoglobulins produced by the immune system to provide protection against SARS-CoV-2. Anti-SARS-CoV-2 IgG can therefore be detected in samples from affected patients. Antibody tests can show whether a person has been exposed to the SARS-CoV-2, and whether or not they potentially show lasting immunity to the disease. With the constant spread of the virus and the high pressure of re-opening economies, antibody testing plays a critical role in the fight against COVID-19 by helping healthcare professionals to identify individuals who have developed an immune response, either via vaccination or exposure to the virus. Many countries have launched large-scale antibody testing for COVID-19. The development of measurement standards for the antibody detection of SARS-CoV-2 is critically important to deal with the challenges of the COVID-19 pandemic. In this study, the SARS-CoV-2 monoclonal antibody is being used as a model system to build capacity in methods that can be used in antibody quantification. Amino acid reference values with corresponding expanded uncertainty of 36.10 ± 1.55 mg/kg, 38.75 ± 1.45 mg/kg, 18.46 ± 0.78 mg/kg, 16.20 ± 0.67 mg/kg and 30.61 ± 1.30 mg/kg have been established for leucine, valine, phenylalanine, isoleucine and proline, respectively. Agreement between nearly all laboratories was achieved for the amino acid analysis within 2 to 2.5 %, with one participant achieving markedly higher results due to a technical issue found in their procedure; this result was thus excluded from the reference value calculations. The relatively good agreement within a laboratory between different amino acids was not dissimilar to previous results for peptides or small proteins, indicating that factors such as hydrolysis conditions and calibration procedures could be the largest sources of variability. Peptide reference values with corresponding expanded uncertainty of 4.99 ± 0.28 mg/kg and 6.83 ± 0.65 mg/kg have been established for ALPAPIEK and GPSVFPLAPSSK, respectively. Not surprisingly due to prior knowledge from previous studies on peptide quantitation, agreement between laboratories for the peptide-based analysis was slightly poorer at 3 to 5 %, with one laboratory's result excluded for the peptide GPSVFPLAPSSK. Again, this level of agreement was not significantly poorer than that achieved in previous studies with smaller or less complex proteins. To reach the main text of this paper, click on Final Report.
Vergleichende Darstellung SARS-CoV-2-spezifischer Nanobodys aus unterschiedlichen Wirtsorganismen
(2021)
Aufgrund der anhaltenden COVID-19-Pandemie werden neutralisierende Therapeutika benötigt. Eine Möglichkeit zur Behandlung stellt die Verwendung monoklonaler Anti-SARS-CoV-2-Immun-globuline dar. Ihre Produktion in Säugetierzellen ist jedoch schwer skalierbar, um den weltweiten Bedarf zu decken. VHH-Antikörper, auch Nanobodys genannt, bieten hierfür eine Alternative, da sie eine hohe Temperaturstabilität aufweisen und eine kostengünstige Produktion in prokaryotischen Wirtsorganismen ermöglichen.
Development of an affinity-based method for the site-selective synthesis of antibody-drug-conjugates
(2021)
For the site-selective synthesis of ADCs, a variety of obstacles must be overcome. Those include designing bifunctional affinity peptides with reasonably low 𝐾𝑑-values that couple to the mAb in a site-selective manner. These peptides should also include a functional group that links the payload to the mAb under mild conditions without adversely affecting it. The bioconjugation between peptide and antibody and the linker between peptide and payload must be stable and durable to provide safety when used for medical purposes. The usage of metals and organic solvents should be minimized. Within the project, new types of functionalized affinity peptides were designed, and their affinity towards the Fc-fragment was determined.
Mit dem Testsystem zur Probe
(2021)
Type-I pyrethroids are frequently used for disinfection purposes on airplanes from and to tropical areas. The WHO (Word Health Organization) defines “disinfection” as the procedure whereby health measures are taken to control or kill the insect vectors of human diseases including dengue, yellow fever and malaria.1 Due to this, a new effective and rapid method for pyrethroids analysis directly in the plane is needed.
To detect type-I pyrethroids, gated materials are constructed for the purpose of finely tuning the movement of a cargo from voids of a mesoporous inorganic support to a solution, in response to a predefined stimulus.2 Antibodies are bound to specific functional groups grafted on the support’s surface with the two-fold aim of closing the mesopores and working as biological receptors for the target compounds.2 A specific opening mechanism, activated selectively in presence of pyrethroids as analytes, is able to control the release of an indicator dye previously loaded inside the inorganic support. As only few molecules of pyrethroids are necessary to open a pore and release a large amount of dyes, the system shows an intrinsic signal amplification quantified as a fluorescence emission intensity.3
Different mesoporous silica supports (from nano- and microparticles to platelets and short fibers) were synthetized, characterized and functionalized following different capping strategies. In this contribution, we will compare the temporal response behaviour of the optimized gated materials to verify if the respective delivery systems are properly closed and how fast they can be opened in presence of the analytes. Our results indicate that the trends of the kinetics observed in solution show a better control of the closing/opening mechanism when the epitope region of the antibody (around 10 nm) properly fits the pore size of the carriers.
Because the incorporation of an antibody-gated dye-delivery system with a conventional test-strip-based lateral-flow assay allows for the detection of analytes down to the ppb level in an easy-to-operate manner and an overall assay time of 2–5 min, which is fast for a biochemical test,3 we carried out first model studies for a lateral flow test assay on membranes, using a smartphone setup for read-out.
Cardiovascular diseases are the number one cause of death worldwide and responsible for 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (2017) [1]. Cardiac Troponin I (cTnI) is part of a triple protein complex and the most important biomarker for acute events such as heart attacks. Once a heart attack occurs, the blood stream within the heart is interrupted and further oxygen supply cannot be maintained. As a result, heart cells undergo apoptosis and their proteins will be released into the blood stream. Within the project CardioMet of the European Metrology Program of Research and Innovation (EMPIR) a biosensor for online-monitoring of acute myocardial infarction by detecting cTnI is being developed.
Antibodies are the most used biomolecules in analytical research. Nevertheless, the sequence and structure information of antibodies is often limited, since manufacturers keep them secret or suppliers sell them under different names. This can make it difficult to reproduce even basic experiments performed in publications as the antibodies used might not be identifiable. To overcome these problems, we developed a simple and cheap method for antibody identification by MALDI-TOF-MS fingerprinting. This technique was used to generate a library of antibody fingerprints, which enables the identification and comparison of antibodies in short time.
The trafficking of illegal drugs by criminal networks at borders, harbors, or airports is an increasing issue in public health as these routes ensure the main supply of illegal drugs. The prevention of drug smuggling, including the installation of scanners and other analytical devices to detect ultra-small traces of drugs within a reasonable time frame, remains a challenge. The presented immunosensor is based on a monolithic affinity column with a large excess of immobilized hapten, which traps fluorescently labeled antibodies as long as the analyte cocaine is absent. In the presence of the drug, some binding sites of the antibody will be blocked, which leads to an immediate breakthrough of the labeled protein, detectable by highly sensitive laser-induced fluorescence with the help of a Peltier-cooled complementary metal-oxide-semiconductor (CMOS) camera. Liquid handling is performed with high-precision syringe pumps and microfluidic chip-based mixing devices and flow cells. The biosensor achieved limits of detection of 23 pM (7 ppt) of cocaine with a response time of 90 seconds and a total assay time below 3 minutes. With surface wipe sampling, the biosensor was able to detect 300 pg of cocaine. This immunosensor belongs to the most sensitive and fastest detectors for cocaine and offers near-continuous analyte measurement.
Silicon photonic micro-ring resonators (MRR) developed on the silicon-on-insulator (SOI) platform, owing to their high sensitivity and small footprint, show great potential for many chemical and biological sensing applications such as label-free detection in environmental monitoring, biomedical engineering, and food analysis. In this tutorial, we provide the theoretical background and give design guidelines for SOI-based MRR as well as examples of surface functionalization procedures for label-free detection of molecules.
After introducing the advantages and perspectives of MRR, fundamentals of MRR are described in detail, followed by an introduction to the fabrication methods, which are based on a complementary metal-oxide semiconductor (CMOS) technology. Optimization of MRR for chemical and biological sensing is provided, with special emphasis on the optimization of waveguide geometry. At this point, the difference between chemical bulk sensing and label-free surface sensing is explained, and definitions like waveguide sensitivity, ring sensitivity, overall sensitivity as well as the limit of detection (LoD) of MRR are introduced. Further, we show and explain chemical bulk sensing of sodium chloride (NaCl) in water and provide a recipe for label-free surface sensing.